281 related articles for article (PubMed ID: 32176310)
1. A Systematic Review of Drug-Induced Pemphigoid.
Verheyden MJ; Bilgic A; Murrell DF
Acta Derm Venereol; 2020 Aug; 100(15):adv00224. PubMed ID: 32176310
[TBL] [Abstract][Full Text] [Related]
2. Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid.
Liu M; Yuan M; Sun W; Li Z; Zhou X; Wang C
Invest New Drugs; 2023 Dec; 41(6):802-807. PubMed ID: 37773473
[TBL] [Abstract][Full Text] [Related]
3. Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab.
Sanfilippo E; Gonzalez Lopez A; Saardi KM
J Drugs Dermatol; 2023 Jul; 22(7):685-686. PubMed ID: 37410035
[TBL] [Abstract][Full Text] [Related]
4. Bullous Pemphigoid Mimicking Cellulitis.
Ivyanskiy I; Dave D; Dweik A; Yeary J; Naguib TM
J Investig Med High Impact Case Rep; 2021; 9():23247096211008585. PubMed ID: 33847152
[TBL] [Abstract][Full Text] [Related]
5. A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy.
Guan S; Zhang L; Zhang J; Song W; Zhong D
Front Immunol; 2022; 13():1068978. PubMed ID: 36685586
[TBL] [Abstract][Full Text] [Related]
6. Two rare cases of bullous pemphigoid associated with immune checkpoint inhibitors.
Mazumder A; Darji K; Smith K; Guo M
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593610
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients.
Miller AC; Temiz LA; Adjei S; Duran MA; Sassmannshausen J; Dominguez A; Thomas C; Schmidt JD; Bernhardt M; Doolittle-Amieva CJ; Moshiri AS; Thompson AJ; Pyoung Kim-Lim P; Mattia AV; Tyring SK
J Drugs Dermatol; 2024 Jun; 23(6):e144-e148. PubMed ID: 38834228
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical markers of herpes simplex virus infection in oral lesions of bullous pemphigoid.
Zhang H; Yu M; Liang G; Li S; Zhao C; Jing K; Feng S
Front Immunol; 2024; 15():1387503. PubMed ID: 38698862
[TBL] [Abstract][Full Text] [Related]
9. Multiple blisters in a 6-month old infant.
Wang PY; Niu H; Yin YK; Yin GW
Pediatr Dermatol; 2024; 41(2):331-333. PubMed ID: 37872651
[No Abstract] [Full Text] [Related]
10. Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis.
Vanner M; Tanner A; Chakera A
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350700
[TBL] [Abstract][Full Text] [Related]
11. Bullous Pemphigoid Causing Successive Emergency Department Visits.
Hsu E; Kinoshita AT; McCoy CE
Clin Pract Cases Emerg Med; 2023 Nov; 7(4):268-270. PubMed ID: 38353200
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous blisters mimicking bullous pemphigoid.
Yu YQ; Wen J; Chen XC; Liu H; Zhang FR
Lancet Oncol; 2024 Feb; 25(2):e91. PubMed ID: 38301707
[No Abstract] [Full Text] [Related]
13. An Urticarial and Acral Manifestation of Bullous Pemphigoid After Vildagliptin Therapy: A Case Report.
Bisht K; Khuraijam S; Theresa Sony H; Kumbhar S
Cureus; 2024 Mar; 16(3):e57054. PubMed ID: 38681395
[TBL] [Abstract][Full Text] [Related]
14. Beyond guidelines: the high-dose challenge in severe bullous pemphigoid-a hospital perspective.
Ko EA; Giustozzi MI; Torre AC; Pagotto V; Riganti J; Ruf M; Mazzuoccolo LD
Int J Dermatol; 2024 Apr; 63(4):e86-e88. PubMed ID: 38152861
[No Abstract] [Full Text] [Related]
15. Recalcitrant course of bullous pemphigoid indicating coexisting hypereosinophilic syndrome: A case report and literature review.
Ganji R; Diab R; Mousavi F; Abdollahimajd F
Clin Case Rep; 2023 Jun; 11(6):e7384. PubMed ID: 37323291
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of clinical manifestations of bullous pemphigoid after treatment with dupilumab.
Mariotti EB; Corrà A; Aimo C; Ruffo di Calabria V; Quintarelli L; Verdelli A; Caproni M
Clin Exp Dermatol; 2024 Mar; 49(4):399-400. PubMed ID: 38011325
[No Abstract] [Full Text] [Related]
17. Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature.
Sonego B; Zelin E; Zalaudek I; di Meo N
Dermatol Reports; 2023 Sep; 15(3):9676. PubMed ID: 37822982
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid: Comparing the prevalence and severity of itch and pain.
Dan J; Sprow G; Diaz D; Kodali N; Patel J; Vazquez T; Werth VP
J Am Acad Dermatol; 2023 Jul; 89(1):159-160. PubMed ID: 36842504
[No Abstract] [Full Text] [Related]
19. Acquired hemophilia A in a Taiwanese patient with bullous pemphigoid.
Wang YH; Wu WC; Hsiao LT; Ma SH; Chen CC; Ho YH
Int J Rheum Dis; 2023 Sep; 26(9):1838-1839. PubMed ID: 37182928
[No Abstract] [Full Text] [Related]
20. Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid.
Wang Q; Ruan Y; Guo F; Zhu H; Pan M
Acta Derm Venereol; 2023 Sep; 103():adv12324. PubMed ID: 37707294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
